Investors Count

1

Pentavere Research Group Funding, Pentavere Research Group Valuation & Pentavere Research Group Revenue

1 Fundings

Pentavere Research Group's latest funding round was a Incubator/Accelerator for on January 3, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/3/2018

Incubator/Accelerator

0

FY undefined

1

Date

1/3/2018

Round

Incubator/Accelerator

Amount

Investors

Valuation

Revenue

0

FY undefined

Sources

1

Pentavere Research Group Investors

1 Investors

Pentavere Research Group has 1 investors. JLabs invested in Pentavere Research Group's Incubator/Accelerator funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/3/2018

1/3/2018

1
Incubator/Accelerator

Incubator/Accelerator

California

First funding

1/3/2018

Last Funding

1/3/2018

Investor

Rounds

1
Incubator/Accelerator

Board Seats

Type

Incubator/Accelerator

Location

California

You May Also Like

Evidation Logo
Evidation

Evidation measures health in everyday life and enables anyone to participate in research and health programs. Evidation is a two-sided platform that connects individuals and enterprises. On the consumer side, the company assists individuals to participate in research including testing of digital health programs. On the enterprise side, Evidation provides biopharma, med-tech, big tech, academic institutions, professional societies, and government partners the ability to: generate evidence; and design, test, and deploy programs that motivate evidence-based action.

Syapse Logo
Syapse

Syapse develops applications that enable the use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. The Syapse Discovery application provides an end-to-end solution for companies and laboratories deploying next-generation sequencing-based diagnostics, from patient sample received to physician report delivered. Discovery's configurable semantic data structure enables users to bring omics data together with traditional medical information to develop and deliver diagnostic tests. The platform's open interfaces enable bioinformaticians and biologists to use their favorite computational tools and annotations.

Owkin Logo
Owkin

Owkin specializes in AI technologies applied to clinical research with the aim of developing better drugs and treatments for patients. The company's purpose is to empower researchers in hospitals, universities and the biopharma industry to i) understand why drug efficacy varies from patient to patient, ii) improve the drug development process and iii) to help identify key drugs and treatments for each individual patient to improve patient outcomes. The company's precision medicine platform aims to enable medical insights for drug discovery and development by connecting life sciences firms with academic researchers and hospitals. The Owkin platform aims to enable partners to uncover siloed datasets while maintaining patient privacy and securing proprietary data using Federated Learning and innovative collaborative AI technology.

Holmusk Logo
Holmusk

Holmusk is a data science and digital therapeutics company with a global presence that is dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases. Holmusk's proprietary technology powers data-driven medicine that leverages analytic and digital tools to address the unmet need in healthcare and pharma-life science.

OncoDNA Logo
OncoDNA

OncoDNA is a provider of personalized molecular analysis for cancer patients.

CareJourney Logo
CareJourney

CareJourney supports health systems contracting for population health to better engage patients in the collection and use of health data to inform health decisions. It enables patients to share health data that is accessible to them, by HIPAA right from providers, with health systems to create a more complete picture of the patient's journey.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.